| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-03-3516 |
| P698 | PubMed publication ID | 15126365 |
| P50 | author | Ralph Weissleder | Q7288259 |
| Ching-Hsuan Tung | Q39184020 | ||
| Xandra O. Breakefield | Q63607934 | ||
| P2093 | author name string | Khalid Shah | |
| Katherine Yang | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3236-3242 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy | |
| P478 | volume | 64 |
| Q34341900 | A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy |
| Q39744489 | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. |
| Q35653261 | Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas |
| Q37140126 | Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy |
| Q37604204 | Brain cancer stem cells. |
| Q37174473 | Cell tracking with optical imaging |
| Q38869957 | Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas |
| Q38960128 | Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors |
| Q33641230 | Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging |
| Q45857108 | Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures |
| Q38090923 | Encapsulated stem cells for cancer therapy |
| Q34474267 | Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas |
| Q64105995 | Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma |
| Q38857484 | Harnessing mesenchymal stem cell homing as an anticancer therapy |
| Q39725116 | Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. |
| Q92756792 | Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy |
| Q55471304 | In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. |
| Q36092724 | Mesenchymal stem cells engineered for cancer therapy |
| Q26799013 | Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities |
| Q37938466 | Migration and fate of therapeutic stem cells in different brain disease models. |
| Q36129726 | Molecular optical imaging: applications leading to the development of present day therapeutics |
| Q36512525 | Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors |
| Q39137284 | Neural stem cell-based gene therapy for brain tumors |
| Q90292756 | New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment |
| Q37836419 | On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds |
| Q34333852 | Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells |
| Q61797115 | Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer |
| Q34240433 | Stem cells as therapeutic vehicles for the treatment of high-grade gliomas |
| Q37420576 | Strategies in gene therapy for glioblastoma. |
| Q37433463 | TRAIL on trial: preclinical advances in cancer therapy |
| Q38730195 | Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors |
| Q35153149 | Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors |
| Q38058733 | Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells |
| Q37356520 | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide |
| Q39460016 | The effect of lentivirus-mediated expression of tumor necrosis factor related apoptosis-inducing ligand and shRNA against Bcl-2 on the growth of lymphoma cells |
| Q37122166 | Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare |
| Q35812718 | Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. |
| Q41920847 | microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis |
Search more.